...
首页> 外文期刊>Drugs: education, prevention, and policy >Gender and regional differences in client characteristics among substance abuse treatment clients in the Europe
【24h】

Gender and regional differences in client characteristics among substance abuse treatment clients in the Europe

机译:欧洲药物滥用治疗客户中客户特征的性别和地区差异

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: To assesses the extent of the gender gap among the treated population of drug users across Europe. Methods: This analysis reports data on 363,170 clients from 4647 treatment units in 23 countries (22 European Union member states and Switzerland). Findings: Overall, males outnumber females by four, but the gender ratio varies not only by geographical region/country, but also by drug. In the majority of countries, the most common primary problem drug is opioids, and the overall gender ratio mirrors the gender ratio of opioid users. In some countries, a considerable proportion of treated drug users have cannabis and stimulants (cocaine/amphetamines/methamphetamines) as primary problem drugs. Stimulants other than cocaine and other drugs have lower, while cannabis has a higher than overall male-to-female gender ratio. Conclusions: The very high male-to-female gender ratios may reveal differential access to treatment. Our findings highlight the need to assess access to treatment for women problem drug users and to make women-focussed programmes more available to increase the proportion of women in drug treatment programmes across Europe.
机译:目的:评估整个​​欧洲吸毒者的治疗人群之间的性别差距。方法:该分析报告了来自23个国家(22个欧盟成员国和瑞士)的4647个治疗单位的363,170位客户的数据。调查结果:总体而言,男性比女性多四名,但性别比例不仅因地理区域/国家而异,而且因毒品而异。在大多数国家中,最常见的主要问题药物是阿片类药物,总体性别比反映了阿片类药物使用者的性别比。在一些国家,相当一部分接受过治疗的吸毒者将大麻和兴奋剂(可卡因/安非他明/甲基安非他明)作为主要问题药物。可卡因和其他药物以外的兴奋剂含量较低,而大麻的性别比例则高于总体。结论:极高的男女比例可能显示出不同的治疗途径。我们的研究结果突出表明,有必要评估有问题的女性吸毒者获得治疗的机会,并使以妇女为重点的方案更加可用,以增加整个欧洲药物治疗方案中妇女的比例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号